Department of Cardiology, University Hospital Coventry/Warwick Medical School, Coventry, United Kingdom.
Good Hope Hospital, Birmingham, United Kingdom.
Heart Rhythm. 2015 Aug;12(8):1756-61. doi: 10.1016/j.hrthm.2015.05.006. Epub 2015 May 9.
Catheter ablation is a curative intervention for common arrhythmias such as supraventricular tachycardia and atrial flutter. Many centers still admit patients overnight after this procedure.
This study was performed to evaluate the safety and cost-effectiveness of same-day standard catheter ablation.
We conducted a retrospective study of all consecutive elective same-day procedures performed between 2010 and 2014. Data were collected on baseline parameters, procedure details and success, postoperative complications, unplanned overnight hospital admissions, and clinical outcome (including mortality) at 4-month follow-up. A cost analysis of potential savings was also performed.
A total of 1142 patients underwent planned same-day electrophysiological study with or without ablation. Radiofrequency ablation was performed in 897 of these patients (mean age ± standard error 56 ± 0.6 years, range 16-95 years, 467 males), with 921 arrhythmias ablated and with complete procedural success in 883 cases (96%). There were 92 unplanned admissions (10.3%): 50 for concealed pathways that required transseptal puncture, 19 for immediate complications (including 9 femoral bleeds and 5 pacemakers for heart block), 12 admitted at the operator's discretion, and 11 for other clinical reasons. All had transthoracic echocardiography after the procedure, and none had significant pericardial effusion. At 4-month follow-up, there were 16 readmissions (1 deep vein thrombosis, 3 pericarditic chest pain, 2 femoral hematomas, 7 palpitations, and 3 others) and 1 death (unrelated to ablation). An overnight stay at our center costs $450 (£300); same-day ablation over this period saved our institution $365,000 (£240,000).
Same-day standard catheter ablation is safe and cost-effective, with significant benefits for patients and health care providers. This is particularly important given the current financial climate.
导管消融术是治疗常见心律失常(如室上性心动过速和心房颤动)的一种有治愈可能的介入治疗方法。许多中心在该手术后仍让患者住院过夜。
本研究旨在评估当日标准导管消融术的安全性和成本效益。
我们对 2010 年至 2014 年期间所有连续进行的择期当日手术进行了回顾性研究。收集了基线参数、手术细节和成功率、术后并发症、计划外过夜住院和 4 个月随访时的临床结局(包括死亡率)的数据。还进行了潜在节省成本的分析。
共有 1142 例患者接受了计划的当日电生理检查,其中包括或不包括消融术。897 例患者(平均年龄±标准误差为 56±0.6 岁,范围为 16-95 岁,467 例男性)接受了射频消融术,消融了 921 种心律失常,883 例(96%)手术完全成功。有 92 例计划外住院(10.3%):50 例为需要经房间隔穿刺的隐匿性旁路,19 例为即刻并发症(包括 9 例股部出血和 5 例因心脏阻滞而植入起搏器),12 例由术者决定住院,11 例为其他临床原因。所有患者在手术后均进行了经胸超声心动图检查,均无明显心包积液。4 个月随访时,有 16 例再入院(1 例深静脉血栓形成、3 例心包炎胸痛、2 例股部血肿、7 例心悸和 3 例其他原因),1 例死亡(与消融无关)。我们中心的过夜费用为 450 美元(300 英镑);在此期间,当日消融术为我们机构节省了 36.5 万美元(24 万美元)。
当日标准导管消融术安全且具有成本效益,对患者和医疗保健提供者均有显著益处。考虑到当前的财务状况,这一点尤为重要。